30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Trauma Surgeon Reflects on Experiences with R&D, FDA and Zimmer Biomet Partnership

ORTHOKNOW interviewed the surgeon inventor of N-force’ to understand his take on the trauma market and the future of implant delivery.

JNJ’s Business Review Day Highlights Company Priorities and Restructuring

Johnson & Johnson/JNJ’s business review day on May 18 filled some gaps in my understanding of the restructuring picture, but some holes remain. Here is what we learned, and what we don't know yet.

Computer-Assisted Technologies Gain Traction in Orthopaedics

The use of computer-assisted surgery systems that incorporate robotics, surgical planning and navigation have the potential to bring reproducible results to orthopaedics through imaging, alignment and guidance tools that control surgical variables. But, will hospitals pay for these technologies?

The Pursuit of Infection Prevention: Curbing Readmissions and Costs

Post-surgical infection control is a priority in the reduction of complications, revisions and costs. It’s a topic of importance along the spectrum of development, from the research level, to start-up, through to the industry’s largest companies.

Medtronic Company Profile

Revenue derived from spine and orthobiologics positions Medtronic as the fifth-largest in the orthopaedic industry. The company achieved sales of $2.9 billion in 2015.

Page Navigation